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the association of gut microbiota 
characteristics in Malawian infants 
with growth and inflammation
Arox W. Kamng’ona  1, Rebecca Young2, charles D. Arnold  2, emma Kortekangas3, 
noel patson4, Josh M. Jorgensen2, elizabeth L. prado  2, David chaima4, chikondi Malamba4, 
Ulla Ashorn3, Yue-Mei fan  3, Yin B. cheung5, per Ashorn3,6, Kenneth Maleta4 & 
Kathryn G. Dewey2
We tested the hypotheses that a more mature or diverse gut microbiota will be positively associated 
with infant growth and inversely associated with inflammation. We characterized gut microbiota 
from the stool samples of Malawian infants at 6 mo (n = 527), 12 mo (n = 632) and 18 mo (n = 629) 
of age. Microbiota diversity and maturity measurements were based on Shannon diversity index 
and microbiota for age Z-score (MAZ), respectively. Growth was calculated as change in Z-scores for 
weight-for-age (WAZ), length-for-age (LAZ) and head circumference-for-age (HCZ) from 6 to 12 mo 
and 12 to 18 mo. Biomarkers of inflammation (alpha-1-acid glycoprotein (AGP) and C-reactive protein 
(CRP)) were measured at 6 and 18 mo. Multivariable models were used to assess the association of each 
independent variable with each outcome. Microbiota diversity and maturity were related to growth 
in weight from 6 to 12 mo, but not to growth in length or head circumference or to growth from 12 
to 18 mo. Microbiota diversity and maturity may also be linked to inflammation, but findings were 
inconsistent.
The human gut is colonized by a vast array of microorganisms, which are largely commensal1. These microor-
ganisms constitute what is known as the gut microbiota, and they play an important role in the development 
of the host immune system2 and many physiological functions that are important for the survival of the host3. 
Alterations to the normal gut microbial status (dysbiosis) have been associated with obesity4, kwashiorkor5 and 
inflammatory diseases6–8. It has been reported that inflammatory conditions such as Crohn’s disease (CD) and 
ulcerative colitis (UC) are related to the loss of enteric bacterial diversity9,10. A recent study in animal models 
demonstrated that enrichment of Enterobacteriaceae was associated with the development of CD, while deple-
tion of this bacterial family led to a reduction in inflammation11. It has also been shown that a depletion of 
Faecalibacterium prausnitzii was associated with the recurrence of CD in mice with chemically induced colitis, 
while supplementing the mice with this bacterium led to a reduction in inflammation12. In healthy children, it is 
reported that there is rapid and high diversification of bacterial microbiome over the first year of life, however this 
diversification is delayed and lower in children with allergy and asthma13,14 or in those who are malnourished15. 
A study in Malawian children demonstrated an association of specific bacterial taxa with environmental enteric 
dysfunction (EED), a chronic condition of intestinal inflammation and blunting of intestinal villi16.
Experimental work in gnotobiotic mice implanted with stool samples from Malawian infants has shown that 
gut microbiota composition and maturity are associated with growth status5,15,17. Furthermore, undernourished 
children exhibited an immature microbiota, which transmitted impaired growth phenotypes in mice models17. 
In the sample of children from the latter study, microbiota maturity was positively associated with anthropo-
metric status at 18 mo of age17, but the analysis was confined to correlations with attained growth status and 
did not examine change in growth status over time. A study in the Gambia reported associations of the gut 
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microbiota with infant morbidity, inflammation and growth18, but the sample size (n = 33) was too small to per-
mit definitive conclusions. Another study reported that linear growth faltering was associated with the presence 
of Acidaminococcus and community-level changes in the gut microbiota19.
While it is clear from these reports that the gut microbiota composition plays an influential role in inflam-
mation and enteropathy16,20, which may be linked to growth faltering21,22, the nature of this relationship and the 
functional consequences of variations in the gut microbiota during infancy remain to be fully understood.
We used prospective data from a large cohort of children in Malawi to investigate whether characteristics of 
the microbiota in infancy are associated with growth and inflammation. We tested the following hypotheses: (i) 
a more mature or diverse microbiota at 6 or 12 mo will be positively associated with infant growth during the 
subsequent six months, based on change in length for age z-score (LAZ), weight for age z-score (WAZ), weight 
for length z-score (WLZ), and head circumference z-score (HCZ), (ii) inverse relationships will be observed 
between a more mature or diverse microbiota and concurrent biomarkers of inflammation at 6 mo and 18 mo, 
and between a more mature or diverse microbiota at 6 mo or 12 mo and future inflammation at 18 mo. We also 
investigated, as a secondary objective, the association of specific bacterial taxa with infant growth, based on 
change in LAZ, WAZ, and WLZ.
Results
Study profile and follow-up outcome. Among the 869 mothers assigned to the follow-up study (Fig. 1), 
761 singleton live births were reported. The women who were not included experienced either spontaneous abor-
tions/stillbirths (n = 20), dropped out of the study (n = 68) or gave birth to twins (n = 20). At 18 mo, 622 children 
completed anthropometric measurements and the rest (n = 138) were lost to follow-up. Data on microbiota com-
position of stool samples were available for 515 children at 6 mo and 630 children at 12 mo. The increase in the 
number of children from 6 to 12 mo was due to the higher prevalence of diarrhoea cases at 6 mo which prevented 
stool collection.
Baseline characteristics and infant gut microbiota characteristics. At baseline, the mothers 
excluded from this sub study were similar to the mothers included in the study for most of the characteristics 
considered (Table 1). However, those excluded were from households with a higher BMI, higher mean asset score 
and lower likelihood of severe food insecurity. The mean (SD) of MAZ was 0.64 (2.92) at 6 mo, −0.28 (2.66) at 
12 mo, and −1.32 (1.76) at 18 mo. The decrease in MAZ score with age suggests a worsening relative microbiota 
maturity in this cohort, which parallels the worsening of height-for-age Z-scores in the same setting. The mean 
Figure 1. Study profile and follow-up.
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(SD) of MAZ, at all time-points in the longitudinal model, was 0.08 (2.48). The mean (SD) of Shannon index 
was 1.61 (0.65) at 6 mo, 2.40 (0.67) at 12 mo, and 2.94 (0.62) at 18 mo. The mean (SD) of Shannon index, at all 
time-points in the longitudinal model, was 2.03 (0.73). Shannon index and MAZ were substantially correlated at 
each time-point. The Spearman’s correlation coefficients were 0.65 at 6 mo, 0.76 at 12 mo, and 0.76 at 18 mo. The 
Spearman’s correlation coefficient for the longitudinal association was 0.49.
Association of microbiota maturity or diversity with infant growth from 6–12 or 12–18 mo. 
There was no significant interaction between MAZ and time regarding change in LAZ, HCZ or WLZ in either 
unadjusted or adjusted models (Table 2). MAZ was negatively associated with change in HCZ (p < 0.0001) and 
positively associated with change in WLZ (p < 0.0001) from 6 to 18 mo in unadjusted models, but these associ-
ations became non-significant in adjusted models. There was an interaction between MAZ and time regarding 
change in WAZ; accordingly, cross-sectional models were examined, which revealed that MAZ at 6 mo was pos-
itively related to change in WAZ from 6 to 12 mo in both unadjusted and adjusted models (Table 3 and Fig. 2), 
whereas there was no significant association of MAZ at 12 mo with change in WAZ from 12 to 18 mo.
The interaction between Shannon index and time was not significant for change in LAZ or HCZ in either 
unadjusted or adjusted models (Table 4). Diversity was not associated with change in LAZ or HCZ from 6 to 
18 mo in unadjusted or adjusted models. There was an interaction between Shannon index and time regarding 
change in WAZ and WLZ (although the latter became marginally significant in the adjusted model) (Table 4); 
accordingly, cross-sectional models were examined, which revealed that diversity was positively related to change 
in WAZ (Table 5 and Fig. 3) and WLZ (Table 5) from 6 to 12 mo in both unadjusted and adjusted models, whereas 
there was no significant association with change in WAZ or WLZ from 12 to 18 mo.
Association of microbiota maturity or diversity with biomarkers of inflammation at 6 and 18 
mo of age. There was no predictive association between MAZ at 6 mo or 12 mo and biomarkers of inflam-
mation at 18 mo (data not shown). MAZ at 6 mo was not associated with concurrent inflammation but MAZ at 
18 mo was associated with inflammation at 18 mo based on CRP concentration and high CRP (Table 6). For a 
one Z-score unit increase in MAZ, there was a 12% decrease in CRP concentration (β = 0.88, 95% CI: 0.88 (0.80, 
0.96), p = 0.003)) and the odds of high CRP decreased by 14% (OR:0.86, 95% CI: (0.78, 0.96), p = 0.009). There 
was a higher percentage of high CRP values at 18 mo for concurrent MAZ below median compared with MAZ 
above median (Fig. 4).
Microbial diversity at 6 mo was associated with AGP at 6 mo but not CRP (Table 6): for a one-unit increase in 
Shannon index, there was a 5.9% increase in AGP concentration (g/L) (β = 1.06, 95% CI: (1.02, 1.10), p = 0.042). 
However, there was no association between microbiota diversity at 6 mo or 12 mo and biomarkers of inflamma-
tion at 18 mo (data not shown). Microbiota diversity at 18 mo was associated with CRP and high CRP at 18 mo, 
while no relationship was observed with AGP or high AGP. For a one-unit increase in Shannon index at 18 mo, 
there was a 36% decrease in CRP (β = 0.64, 95% CI: (0.55, 0.92), p = 0.01) concentration at 18 mo, and the odds of 
a high CRP decreased by 32% (OR = 0.68, 95% CI: (0.50, 0.93), p = 0.016). There was a higher percentage of high 
CRP values at 18 mo for concurrent Shannon index below median compared with Shannon index above median 
(p < 0.001) (Fig. 4).
taxa associated with infant growth. Because we found that MAZ and Shannon index at 6 mo were 
related to infant growth from 6 to12 mo, we examined the specific taxa at 6 mo associated with growth for the 
Characteristic Included Excluded p-value
Participants, n 691 707
Maternal age at enrollment, years 25.2 (5.9) 24.8 (6.2) 0.20
Maternal height, cm 156.1 (5.7) 156.0 (5.6) 0.68
Maternal BMI, kg/m2 22.0 (2.8) 22.4 (2.9) 0.04
Maternal education completed, years 3.8 (3.5) 4.2 (3.4) 0.08
Positive malaria RDT of the mother at enrollment 22.4% 23.9% 0.52
HIV+ status of the mother 11.9% 15.5% 0.06
Mode of delivery (% with vaginal delivery) 94.9% 93.4% 0.28
Food insecure household 38.9% 33.1% 0.03
Access to sanitary facility (% with flash toilet) 9.6% 8.5% 0.57
Household asset Z-score −0.08 (1.0) 0.09 (1.0) 0.01
LAZ at 6 mo −1.3 (1.1) −1.1 (1.1) 0.08
WAZ at 6 mo −0.57 (1.2) −0.56 (1.1) 0.89
High AGP at 6 mo 64.4% —
High CRP at 6 mo 28.8% —
Table 1. Characteristics of included and excluded participants. Values are in mean (standard deviation) or 
percentages. p-values are obtained from t-test (continuous variables) or chi-square test (proportions). BMI 
(Body mass index). RDT (rapid diagnostic test). LAZ (Length-for-age Z-score). WAZ (Weight-for-age Z score). 
AGP (Alpha-1 acid glycoprotein). C-reactive protein (CRP).
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6–12 mo period. No further analysis of specific taxa at 12 mo was conducted since there was no significant 
association of either MAZ or Shannon index at 12 mo with change in Z scores from 12 to18 mo. At 6 mo, there 
were 7428 OTUs in total; following filtering steps, only 291 OTUs remained. Of these, 64% (187/291) and 60% 
(174/291) were associated with Shannon index and MAZ (p < 0.05), respectively. Only a few of the 291 OTUs 
were significantly associated with at least one of the growth outcomes (change in LAZ, WAZ or WLZ, Figs 5 
and 6), either positively (shown in green) or negatively (shown in red). Those shown in light green or pink were 
significant only before the FDR correction; those in dark green or red remained significant after the FDR correc-
tion. Generally, there were more positive associations than negative associations. In addition, there were very few 
associations with linear growth (change in LAZ), whereas numerous significant associations with weight (change 
in WAZ or WLZ) were observed. The associations with change in WAZ and WLZ generally occurred in the same 
direction, i.e. if a given taxon was positively associated with change in WAZ, it was also positively associated with 
change in WLZ, with the same trend observed for negative associations.
Regarding the specific taxa at 6 mo associated with change in weight between 6 and 12 mo, we detected 8 
OTUs that were negatively associated with change in WAZ. These included Actinomyces, Actinomyces graevenit-
zii, Atopobium parvulum (Fig. 5) and Lactococcus, Streptococcus, Streptococcus mitis, and Clostridium difficile 
(Fig. 6). We detected 20 OTUs that were positively associated with change in WAZ. These included Prevotella, 
Campylobacter, Enterobacteriaceae (family), Enterobacter ludwigii, Enterobacter_sp_A5_2, Klebsiella (genus), 
Salmonella enterica (Fig. 5) and Clostridium Lactobacillus rogosae, Eubacterium hallii, Eubacterium rectale, 
Microbiota maturity (MAZ)
Outcome (n)
Unadjusted
Outcome (n)
Adjusted
β of MAZ in model 
without interaction
p-value
β of MAZ in model 
without interaction
p-value
Interaction, 
age-interval * 
MAZ
β of 
MAZ
Interaction, 
age-interval * 
MAZ
β of 
MAZ
LAZ (1058) −0.01 (−0.02, 0.01) 0.308 0.364 LAZ (993) −0.01 (−0.02, 0.01) 0.393 0.371
HCZ (1052) −0.18 (−0.22, −0.14) 0.101 <0.0001 HCZ (998) −0.01 (−0.02, 0.00) 0.199 0.171
WLZ (1059) 0.01 (0.00, 0.03) 0.125 <0.0001 WLZ (992) 0.01 (−0.01, 0.03) 0.159 0.37
WAZ (1057) 0.019 WAZ (999) 0.039
Table 2. The longitudinal association of microbiota maturity at 6 or 12 mo with infant growth from 6 to 18 
mo of age. The relationship between microbiota maturity (MAZ) and each pre-defined outcome (LAZ, length-
for-age z score; HCZ, head-circumference z score; WLZ, weight-for-length z score; and WAZ, weight-for-
age z score) was tested for significance in multivariate models while controlling for other factors, including 
nutrition intervention group. The β of MAZ in the model without the interaction term was derived from a 
model including terms for the age interval and MAZ, but no interaction of age-interval and MAZ. The term 
‘Age-interval *MAZ’ tested the significance of the interaction between time and microbiota maturity in a 
longitudinal model. The repeated measures models included two age intervals based on child’s age; in the first 
age interval, the response variable was change in z-score between 6 and 12 mo and the predictor was MAZ at 6 
mo, and in the second age interval the response was change in z-score between 12 and 18 mo and the predictor 
was MAZ measured at 12 mo. The p-values were obtained from repeated measures ANCOVA. The models were 
adjusted for the following pre-specified covariates: intervention group; child age on day of stool collection; 
maternal age, height, body mass index, parity, education, HIV status, and hemoglobin at enrollment; household 
assets, food security, source of drinking water (tap water vs any other source), residential location and access to 
sanitary facility (water closet or ventilation improved pit latrine vs. none or regular pit latrine); season at time of 
stool sample collection; mode of delivery (vaginal or cesarean); site of delivery; and child sex.
Outcome
MAZ time point of 
measurement (n)
Unadjusted Adjusted
β of MAZ
p of β of 
MAZ β of MAZ
p of β of 
MAZ
ΔWAZ 
(6–12 mo) 6 mo (n = 468) 0.03 (0.01, 0.05) 0.001 0.02 (0.00, 0.05) 0.033
ΔWAZ 
(12–18 mo) 12 mo (n = 592) −0.02 (−0.03, 0.01) 0.463 −0.01 (−0.03, 0.01) 0.35
Table 3. Association of microbiota maturity with growth in weight when the interaction between age interval 
and MAZ was significant. The relationship between microbiota maturity (MAZ) and change in WAZ (weight-
for-age z score) when there was a significant interaction between age interval and MAZ. The relationship 
was assessed for both unadjusted and adjusted models. The p-values were obtained from repeated measures 
ANCOVA. The models were adjusted for the following pre-specified covariates: intervention group; child age on 
day of stool collection; maternal age, height, body mass index, parity, education, HIV status, and hemoglobin at 
enrollment; household assets, food security, source of drinking water (tap water vs any other source), residential 
location and access to sanitary facility (water closet or ventilation improved pit latrine vs. none or regular pit 
latrine); season at time of stool sample collection; mode of delivery (vaginal or cesarean); site of delivery; and 
child sex.
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Faecalibacterium prausnitzii, and Ruminococcus obeum (Fig. 6). There were 5 OTUs that were negatively asso-
ciated with change in WLZ and 23 OTUs positively associated with change in WLZ, however these associations 
did not remain significant after FDR correction. Overall, we observed that Proteobacteria and Bacteroidetes were 
positively associated with weight growth, while Actinobacteria (except for Bifidobacterium dentium) taxa were 
negatively associated with weight growth (Fig. 5).
Regarding the specific taxa associated with growth in length, we observed 10 and 7 OTUs (Figs 5 and 6) that 
were negatively and positively associated with change in LAZ, respectively. However, these associations did not 
remain significant following FDR adjustment.
Taxa associated with inflammatory biomarkers. We examined taxa at 6 mo associated with AGP 
concentration at 6 mo because we observed a significant association of that outcome with microbiota diversity 
at 6 mo in the primary analyses. We detected 5 OTUs that were either negatively or positively related to AGP 
at 6 mo. We observed that when Slackia isoflavoniconvertens species was present at any abundance, AGP was 
Figure 2. Association of MAZ at 6 mo of age with change in WAZ from 6 to 12 mo of age. The figure was 
generated using data from adjusted cross-sectional models and shows a positive relationship between 
microbiota maturity (MAZ) and change in WAZ from 6 to 12 mo (p = 0.033). The positive relationship was also 
observed in un-adjusted models (p = 0.001).
Outcome (n)
Microbiota diversity (Shannon index)
Unadjusted Adjusted
β of Shannon index 
in model without 
interaction
p-value
β of Shannon index 
in model without 
interaction
p-value
Interaction, age-
interval * Shannon 
index
β of 
Shannon 
index
Interaction, age-
interval * Shannon 
index
β of 
Shannon 
index
LAZ (1058) −0.02 (−0.08, 0.04) 0.365 0.539 −0.03 (−0.09, 0.04) 0.485 0.397
HCZ (1052) −0.01 (−0.06, 0.05) 0.158 0.838 −0.01 (−0.06, 0.05) 0.338 0.847
WLZ (1059) 0.025 0.03 (−0.04, 0.10) 0.054 0.436
WAZ (1057) 0.006 0.037
Table 4. The longitudinal association of Shannon diversity index at 6 or 12 mo with infant growth from 6 to 
18 mo of age. The relationship between microbiota diversity (Shannon index) and growth (LAZ, length-for-
age z score; HCZ, head-circumference z score; and WLZ, weight-for-length z score) was tested for significance 
in multivariate models while controlling for other factors, including nutrition intervention group. The β of 
Shannon index in the model without the interaction term was derived from a model including terms for the 
age interval and Shannon index, but no interaction of age-interval and Shannon index. The term ‘Age-interval 
*H’ tested the significance of the interaction between age interval and microbiota diversity in a longitudinal 
model. The repeated measures models included two age intervals based on child’s age; in the first age interval, 
the response variable was change in z-score between 6 and 12 mo and the predictor was Shannon index at 6 mo, 
and in the second age interval, the response was change in z-score between 12 and 18 mo and the predictor was 
Shannon index measured at 12 mo. The p-values were obtained from repeated measures ANCOVA. The models 
were adjusted for the following pre-specified covariates: intervention group; child age on day of stool collection; 
maternal age, height, body mass index, parity, education, HIV status, and hemoglobin at enrollment; household 
assets, food security, source of drinking water (tap water vs any other source), residential location and access to 
sanitary facility (water closet or ventilation improved pit latrine vs. none or regular pit latrine); season at time of 
stool sample collection; mode of delivery (vaginal or cesarean); site of delivery; and child sex.
6Scientific RepoRtS |         (2019) 9:12893  | https://doi.org/10.1038/s41598-019-49274-y
www.nature.com/scientificreportswww.nature.com/scientificreports/
lower compared to when the species was absent (β = −0.14 (−0.27, −0.01), p = 0.03). The presence of other taxa 
such as Ruminococcus gnavus (β = −0.16 (0.05, 0.27), p = 0.01), Lactobacillus (β = −0.26 (0.08, 0.45), p = 0.01), 
Clostridiales (β = −0.13 (0.04, 0.23), p = 0.01) and Clostridium (β = 0.1 (0.00, 0.20), p = 0.05) was positively 
associated with AGP at 6 mo. The relationship between Slackia isoflavoniconvertens, Ruminococcus gnavus, 
and Lactobacillus and AGP remained significant after FDR correction. To help understand these associations, 
we further examined the association of these taxa with Shannon index. We observed a positive and significant 
relationship of Ruminococcus gnavus (β = 0.22 (0.08, 0.35), p = 0.0018), Slackia isoflavoniconvertens (β = 0.61 
(0.44, 0.78), p = 0.0001), Clostridiales (β = 0.27 (0.15, 0.39), p = 0.0001) and Clostridium (β = 0.32 (0.20, 0.45), 
p = 0.0001) with Shannon index at 6 mo. Each relationship remained significant after FDR correction. However, 
Enterobacteriaceae and Lactobacillus were not associated with Shannon index.
We examined taxa at 18 mo associated with CRP concentration at 18 mo because we observed significant 
associations of that outcome with both microbiota maturity and diversity at 18 mo. Several taxa exhibited a 
negative association with CRP at 18 mo including Prevotella (β = −1 (−1.9, −0.11), p = 0.03) and Leuconostoc 
(β = −0.87 (−1.59, −0.16), p = 0.02), whereas Clostridium innocuum (β = 0.89 (0.18, 1.6), p = 0.01) exhibited a 
positive association. The relationship between Clostridium innocuum and CRP at 18 months remained significant 
after FDR correction. Except for Leuconostoc, which was not related to Shannon index or MAZ, Prevotella and 
Clostridium innocuum were positively related to Shannon index (β = 0.29 (0.16, 0.41), p < 0.0001; β = 0.19 (0.03, 
0.34), p = 0.02, respectively) and MAZ (β = 0.29 (0.16, 0.41) p < 0.0001; β = 0.19 (0.03, 0.34), p = 0.02, respec-
tively) at 18 mo.
Outcome
Shannon index 
time point of 
measurement
Unadjusted Adjusted
β of Shannon index
p of β of 
Shannon 
index β of Shannon index
p of β of 
Shannon 
index
ΔWAZ (6–12 mo) 6 mo 0.14 (0.05, 0.25) 0.002 0.10 (0.01, 0.19) 0.023
ΔWAZ (12–18 mo) 12 mo −0.03 (−0.11, 0.05) 0.469 0.04 (−0.15, 0.05) 0.35
ΔWLZ (6–12 mo) 6 mo 0.16 (0.05, 0.28) 0.005 0.15 (0.04, 0.26) 0.01
ΔWLZ (12–18 mo) 12 mo −0.01 (−0.10, 0.09) 0.879 −0.03 (−0.13, 0.07) 0.59
Table 5. Association of microbiota diversity with growth in weight when the interaction between age interval 
and Shannon index was significant. The relationship between microbiota diversity (Shannon index) and change 
in WAZ (weight-for-age z score) and WLZ (weight-for-length z score) when there was a significant interaction 
between age interval and Shannon index. The relationship was assessed for both unadjusted and adjusted 
models. The p-values were obtained from repeated measures ANCOVA. The models were adjusted for the 
following pre-specified covariates: intervention group; child age on day of stool collection; maternal age, height, 
body mass index, parity, education, HIV status, and hemoglobin at enrollment; household assets, food security, 
source of drinking water (tap water vs any other source), residential location and access to sanitary facility 
(water closet or ventilation improved pit latrine vs. none or regular pit latrine); season at time of stool sample 
collection; mode of delivery (vaginal or cesarean); site of delivery; and child sex.
Figure 3. Association between microbiota diversity at 6 months of age and change in WAZ from 6 to 12 mo of 
age. The figure was generated using data from adjusted cross-sectional models and shows a positive relationship 
of Shannon index with change in WAZ from 6 to 12 mo (p = 0.023). The positive relationship was also observed 
in un-adjusted models (p = 0.002).
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Discussion
We investigated whether characteristics of the gut microbiota in infancy are associated with subsequent growth 
and inflammation. We first tested the hypothesis that a more mature or diverse microbiota will be positively 
associated with infant growth. There was no association between MAZ and growth from 6 to 18 mo in relation to 
LAZ, HCZ or WLZ. MAZ at 6 mo was positively, though weakly, related to change in WAZ from 6 to 12 mo, while 
MAZ at 12 mo was not related to change in WAZ from 12 to 18 mo. We observed no association between Shannon 
index and change in LAZ or HCZ from 6 to 18 mo. However, there was a positive relationship of Shannon index 
at 6 mo with change in WAZ and WLZ from 6 to 12 mo, whereas no association of Shannon index at 12 mo with 
change in WAZ or WLZ from 12 to 18 mo was observed. Next, we tested the hypothesis that a more mature or 
diverse microbiota will be inversely related to biomarkers of inflammation (CRP and AGP). At 6 mo, microbiota 
maturity was not related to either biomarker, but Shannon index was positively related to AGP concentration at 
the same time point. At 18 mo, both microbiota maturity and Shannon index were inversely related to CRP (but 
not AGP) concentration at the same time point.
The positive associations of both MAZ and Shannon index with growth in weight between 6 and 12 mo, but 
not between 12 and 18 mo, suggests that the second half of infancy is a critical period. Around 6 mo, the transition 
from predominant breastfeeding to a mixed diet with increasing amounts of complementary foods is underway, 
Predictor Variable
Age for 
measured 
inflammation 
outcomes
Inflammation outcome variables
Alpha-1 acid 
glycoprotein (AGP)*
C-reactive protein 
(CRP)* High AGP High CRP
β- value
(95% CI) p-value
β-value
(95% CI) p-value
OR
(95% CI) p-value
OR
(95% CI) p-value
MAZ (6 mo)
6 mo
1.01
(0.99, 1.03) 0.17
0.97
(0.90, 1.06) 0.47
1.03
(0.90, 1.09) 0.849
1.09
(0.99, 1.19) 0.072
Shannon index
(6 mo)
1.06
(1.02, 1.10) 0.042
0.92
(0.86, 1.89) 0.6
1.39
(0.97, 2.00) 0.072
1.04
(0.71, 1.54) 0.831
MAZ (6 mo)
18 mo
1.00
(0.98, 1.01) 0.780
0.99
(0.92, 1.06) 0.748
1.00
(0.91, 1.09) 0.943
1.03
(0.94, 1.13) 0.501
Shannon index
(6 mo)
0.97
(0.91, 1.03) 0.375
0.90
(0.66, 1.22) 0.487
1.00
(0.71, 1.41) 0.992
1.12
(0.79, 1.60) 0.530
MAZ (18 mo)
18 mo
1.01
(0.98, 1.03) 0.89
0.88
(0.80, 0.96) 0.0034
0.97
(0.88, 1.09) 0.618
0.86
(0.78, 0.96) 0.009
Shannon index
(18 mo)
0.97
(0.92, 1.03) 0.22
0.64
(0.55, 0.92) 0.01
0.85
(0.62, 1.16) 0.31
0.68
(0.50, 0.93) 0.016
Table 6. The association of microbiota maturity (MAZ) or microbiota diversity (Shannon index) at 6 or 18 mo 
with inflammation. Inflammation was assessed by measuring Alpha-1 acid glycoprotein (AGP) and C-reactive 
protein (CRP) from blood/plasma as biomarkers reported as g/L and mg/L respectively. High AGP was defined 
as [AGP] value >1.0 g/L and high CRP as [CRP] value >5.0 mg/L. The association of MAZ and Shannon index 
with inflammation was assessed by controlling for child age on day of stool collection; maternal age, height, 
body mass index, parity, education, HIV status, and hemoglobin at enrollment; household assets, food security, 
source of drinking water (tap water vs any other source), residential location and access to sanitary facility 
(water closet or ventilation improved pit latrine vs. none or regular pit latrine); season at time of stool sample 
collection; mode of delivery (vaginal or cesarean); site of delivery; and child sex. There was no difference in 
findings from the unadjusted and adjusted models, so this table only shows adjusted models. *Beta values are 
back-transformed from a natural log transformation.
Figure 4. Association of inflammation with MAZ and microbiota diversity. The figure shows the concurrent 
association of acute inflammation with MAZ and Shannon index at 18 mo of age. The light grey bars show the 
percentage of high CRP for values of MAZ or Shannon index below the median. The dark grey bars show the 
percentage of high CRP for values of MAZ or Shannon index above the median. The percentage with high CRP 
is higher for values of MAZ (p = 0.111) or Shannon index (p < 0.001) below the median.
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which has been associated with a sudden and major shift in the gut microbiome profile23 as demonstrated in 
piglets24. Variations in the microbiota profile at 12 mo may be less consequential for growth than those at earlier 
ages, given that complementary foods are well established in the diet by that age. In a cross-sectional study among 
children in Bangladesh at 18 mo of age, WLZ was not correlated with Shannon index but was inversely correlated 
with MAZ15. The lack of association of WLZ with microbial diversity is consistent with our findings during the 
12–18 mo period, but the inverse association with MAZ is in conflict with our findings. The longitudinal nature 
of our study, and the inclusion of data on the gut microbiota during the first year of life, provide information that 
is not available from previous studies, which may help to explain these contradictory findings.
Regarding the specific taxa that might be related to growth from 6 to 12 mo, we found several associations that 
remained significant following FDR correction. Change in WAZ between 6 and 12 mo was positively associated 
with presence of several strains that are capable of hydrolysing cellulose such as Prevotella, Ruminococcus sp, 
Clostridium sp, Eubacterium sp and Bacteroides25,26. Prevotella is also thought to improve glucose metabolism 
through promotion of increased glycogen storage27. It is possible that the metabolic role played by Prevotella and 
other cellulolytic bacteria increases the availability of glucose which subsequently promotes weight growth. An 
unexpected finding was a significant positive association of Salmonella enterica with weight growth. Salmonella 
enterica is a foodborne pathogen responsible for inflammatory disease in the intestine following diarrhoea and is 
implicated in many deaths globally28,29. Taxa such as Actinobacteria (Actinomyces, Atopobium) and Firmicutes 
(Lactococcus, Streptococcus, and Clostridium) were negatively associated with change in WAZ. In contrast to 
our findings, a previous study in mice at weaning age showed that Firmicutes promoted weight gain, presumably 
because of the ability of these bacteria to digest complex sugars30,31; however, this could be driven by other genera 
and not necessarily Lactococcus, Streptococcus or Clostridium. In addition, metabolic effects in mice may not 
necessarily predict outcomes in humans. Although it has previously been reported that linear growth faltering is 
associated with taxa such as Acidaminococcus19, we did not find any significant association of any given taxa with 
linear growth in our study.
With regard to the associations between the microbiota and markers of inflammation, the finding of a concur-
rent positive relationship between Shannon index and AGP (a long-term biomarker of inflammation) at 6 mo and 
not CRP (a short-term biomarker of inflammation) was unexpected. Raised AGP levels (with normal CRP levels) 
are normally observed in subjects who have recovered from inflammatory conditions and are convalescing32. It 
Bivariate
LAZ WAZ WLZ
Proteobacteria; Salmonella; OTU4384058
Proteobacteria; Klebsiella; OTU4376230
Proteobacteria; Escherichia; OTU4375000
Proteobacteria; Enterobacter; OTU114462
Proteobacteria; Enterobacter; OTU581021
Proteobacteria; Enterobacter; OTU91557
Proteobacteria; und; OTU1010113
Proteobacteria; und; OTU688934
Proteobacteria; Campylobacter; OTU302158
Proteobacteria; Sutterella; OTU178885
Bacteroidetes; Prevotella; OTU301253
Bacteroidetes; Prevotella; OTU297414
Bacteroidetes; Prevotella; OTU180825
Bacteroidetes; Parabacteroides; OTU4365130
Bacteroidetes; Parabacteroides; OTU578016
Bacteroidetes; Parabacteroides; OTU4329571
Bacteroidetes; Bacteroides; OTU4439360
Bacteroidetes; Bacteroides; OTU4256470
Actinobacteria; Eggerthella; OTU4393532
Actinobacteria; Atopobium; OTU4451251
Actinobacteria; Bifidobacterium; OTU553611
Actinobacteria; Corynebacterium; OTU912997
Actinobacteria; Actinomyces; OTU875735
Actinobacteria; Actinomyces; OTU12574
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Figure 5. Taxa specific associations with growth. The figure shows negative and positive associations of specific 
taxa with changes in z-scores between 6 and 12 mo: LAZ, length-for-age z score; WAZ, weight-for-age z score; 
and WLZ, weight-for-length z score. The negative associations that were significant only before FDR correction 
(at 15%) and those that remained significant after correction are shown in pink and dark red, respectively. 
Positive associations that were significant only before correction are shown in light green colour, while those 
that remained significant after correction are in dark green colour.
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is possible that inflammation at 6 mo may have been chronic (i.e pre-existing from early infancy) and thus that 
inflammation affected microbial composition rather than vice versa. At 18 mo however, a concurrent inverse 
relationship was observed between microbiota characteristics and CRP, though not AGP. Raised CRP levels are 
associated with recent infection with or without clinical evidence of disease32. The percentage of children with 
high CRP values was elevated among those with MAZ or Shannon index values below the median (compared 
with those above the median), by 6 and 12 percentage points, respectively. This suggests that a more mature and 
diverse microbiota community may help to prevent inflammation, but we cannot rule out the possibility that the 
relationship works in the opposite direction, i.e., that inflammation affects microbial diversity. Previous studies in 
adults demonstrated that lower alpha diversity and gene count of the gut microbiome were associated with higher 
levels of high sensitivity CRP4,33. High sensitivity CRP is an inflammatory biomarker for myocardial infarction, 
stroke and peripheral arterial diseases34. Mucosal inflammation in inflammatory bowel disease (IBD) has been 
associated with a significant reduction in the diversity of the gut microbiota measured by Shannon index35–37. 
Although determining whether variations in microbiota composition contribute to inflammation is a challenge 
in humans, it has recently been demonstrated in mice that a reduction in airway microbiota diversity was asso-
ciated with elevated allergic respiratory inflammation38, suggesting that an altered microbiota profile can affect 
inflammation.
At 6 mo, several taxa were positively associated with AGP concentration including Ruminococcus gnavus, 
Lactobacillus and Clostridiales. Previous studies have reported an enrichment of Ruminococcus gnavus and 
Lactobacillus in children with IBD, which is consistent with our findings, while Clostridiales were depleted in 
individuals with IBD relative to healthy controls9,39–41, which is in conflict with our results. Several taxa present 
at 18 mo were positively associated with concurrent inflammation including Prevotella, Clostridium innocuum 
and Leuconostoc. While Prevotella may be beneficial because of its cellulolytic activities, it has also been linked 
to chronic inflammatory conditions such as arthritis as well as mucosal and systemic T-cell activation in HIV 
infected subjects not on therapy42. Because Prevotella is a genus comprised of many different species, it is possible 
Bivariate
LAZ WAZ WLZ
Firmicutes; Veillonella; OTU4388775
Firmicutes; Veillonella; OTU4422456
Firmicutes; Veillonella; OTU4318671
Firmicutes; und; OTU128382
Firmicutes; Erysipelotrichaceae; OTU182483
Firmicutes; Erysipelotrichaceae; OTU179018
Firmicutes; Ruminococcus; OTU184238
Firmicutes; Faecalibacterium; OTU181422
Firmicutes; Faecalibacterium; OTU4381430
Firmicutes; Faecalibacterium; OTU265871
Firmicutes; Faecalibacterium; OTU193644
Firmicutes; Faecalibacterium; OTU189092
Firmicutes; Faecalibacterium; OTU188676
Firmicutes; Faecalibacterium; OTU186772
Firmicutes; Faecalibacterium; OTU199293
Firmicutes; Faecalibacterium; OTU193873
Firmicutes; und; OTU195436
Firmicutes; Roseburia; OTU3924627
Firmicutes; Eubacterium; OTU180999
Firmicutes; Eubacterium; OTU3609545
Firmicutes; Eubacterium; OTU192406
Firmicutes; Eubacterium; OTU4447605
Firmicutes; Clostridium; OTU4445673
Firmicutes; Clostridium; OTU170652
Firmicutes; Clostridium; OTU3576174
Firmicutes; Clostridium; OTU606927
Firmicutes; Clostridium; OTU4331360
Firmicutes; Clostridium; OTU182289
Firmicutes; und; OTU190502
Firmicutes; und; OTU186732
Firmicutes; und; OTU179267
Firmicutes; und; OTU176980
Firmicutes; Streptococcus; OTU4307484
Firmicutes; Streptococcus; OTU1079708
Firmicutes; Streptococcus; OTU4442130
Firmicutes; Streptococcus; OTU1059655
Firmicutes; Streptococcus; OTU300658
Firmicutes; Lactococcus; OTU1100972
Firmicutes; Weissella; OTU663969
Firmicutes; Leuconostoc; OTU4365141
Firmicutes; Pediococcus; OTU773251
Firmicutes; Lactobacillus; OTU4463108
Firmicutes; Lactobacillus; OTU4414476
Firmicutes; Lactobacillus; OTU4305372
Firmicutes; Lactobacillus; OTU533133
Firmicutes; Lactobacillus; OTU318764
Firmicutes; Enterococcus; OTU3697034
Firmicutes; Enterococcus; OTU810399
Firmicutes; und; OTU3134492
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Figure 6. Taxa specific associations with growth, for Firmicutes phylum only. The figure shows negative and 
positive association of specific taxa changes in z-scores between 6 and 12 mo: LAZ, length-for-age z score; WAZ, 
weight-for-age z score; and WLZ, weight-for-length z score. The negative associations that were significant only 
before FDR correction at 15% and those that remained significant after correction are shown in pink and dark 
red, respectively. Positive associations that were significant only before correction are shown in light green color, 
while those that remained significant after correction are in dark green color.
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that the differences in the observed metabolic functions attributed to Prevotella are due to different species pres-
ent within the genus, thus the species diversity within a given genus ought to be taken into account when inter-
preting results.
Strengths of our study include a large sample size and a longitudinal approach to the analysis of the data, 
which allowed us to study the associations between microbiota characteristics and infant outcomes over time. 
In addition, our study included training of research personnel in good clinical practices, as well as maintaining a 
high level of standardization and quality assurance during data collection. One of the limitations was that there 
were some statistically significant differences in two baseline characteristics (number of food insecure house-
holds, household asset Z-score) between included and excluded participants. Although these may not necessarily 
affect the conclusions drawn from the analysis, they may affect the generalizability of the findings to the study 
population. Another limitation is the exploratory nature of this study. While we had pre-specified hypotheses for 
the associations of the outcomes with MAZ and Shannon index, the taxa-specific analyses were entirely explor-
atory and therefore hypothesis generating. We also conducted multiple hypothesis testing but did not perform 
a statistical correction for multiple hypothesis testing (except for the taxa-specific analyses) because the growth 
outcomes are closely related to each other. Thus, it is possible that some findings could be due to chance.
In conclusion, microbiota maturity and diversity (at 6 mo) were associated with growth in weight but not length 
between 6 and 12 mo, while no such association was observed between microbiota characteristics at 12 mo and growth 
outcomes between 12 and 18 mo, in our setting. These findings suggest that microbiota characteristics may play an 
important role in weight gain during the second half of the first year of life. Microbiota diversity and maturity may also 
be linked to reduced inflammation, but findings were inconsistent, and the potential causal direction is unclear. We 
recommend further research in other settings to evaluate whether these associations are replicated.
Methods
Study setting and design. The data for the study reported in this article were obtained from a clinical trial 
conducted in Malawi. The details of the study known as the International Lipid-based Nutrient Supplements 
DYAD (iLiNS-DYAD) trial have been reported previously43,44. Briefly, we enrolled 1391 pregnant mothers above 
15 years of age and ≤20 gestational weeks from the antenatal clinics of two health centres and two hospitals in 
Mangochi district. Based on the sample size needed for the original iLiNS-DYAD trial, 869 mothers were allo-
cated to 18 mo follow-up study after delivery and the singleton infants born to these mothers were participants 
for the current analysis. Infants born to the remaining 522 women who were assigned to pregnancy intervention 
only were not included (Fig. 1).
At baseline, the following data were collected by trained study personnel: Socio-demographic status, maternal 
age, height, body mass index (BMI), parity, education, HIV status, hemoglobin concentration, household assets, 
food security, source of drinking water (tap water vs any other source), access to sanitary facility (water closet or 
ventilation improved pit latrine vs. none or regular pit latrine) and season. We established maternal HIV status 
using a whole-blood antibody rapid test (Alere Determine HIV-1/2, Alere Medical Co, Ltd. and Uni-Gold HIV; 
Trinity Biotech plc)44. Details of the trial have been recorded at the clinical trial registry at the National Institutes 
of Health (USA) (www.clinicaltrials.gov), under the registration number NCT01239693. The trial was conducted 
by adhering to the Good Clinical Practice guide-lines and ethical standards of the Helsinki Declaration. We 
obtained ethical clearance for the study from the University of Malawi College of Medicine Research and Ethics 
Committee (COMREC) and the ethics committee at Tampere University Hospital District, Finland. An informed 
consent was obtained from each participant before being enrolled into the study. An independent data safety and 
monitoring board monitored the incidence of suspected serious adverse events (SAEs) during the trial.
faecal sample collection. Mothers were trained to collect faecal samples (generally in the morning) from 
participating children in their homes at 6, and 12 mo of age. The mothers were provided with sample collection 
tubes a day before the scheduled sample collection visit. Samples from suspected diarrhoea cases (>3 stools 
a day and markedly more liquid) were excluded, and the visit was rescheduled for two weeks later. The tubes 
containing faecal matter were sealed, labelled, and immediately stored in a Ziploc bag on a frozen ice pack in a 
cooler bag. The samples were transported to a satellite clinic within 6 hours of sample collection for a brief storage 
at −20 °C before being transported to the central clinic in Mangochi for storage at −80 °C within 48 hours. The 
samples were later shipped on dry ice to the USA for culture-independent analysis of community composition 
at Washington University, St. Louis, MO. Sample collection spanned all the three seasons of Malawi: warm-wet 
season (November-April), cool-dry-winter season (May-August), and hot-dry season (September–October).
DNA Purification and 16S rRNA Sequencing. The isolation of DNA from stool and 16S rRNA gene 
amplicon sequencing was conducted as described elsewhere45. Stool samples were homogenized by grinding 
in the presence of liquid nitrogen prior to DNA extraction. DNA libraries were prepared by amplifying the V4 
region (~255 bp) of the 16S rRNA gene. The DNA libraries were then sequenced on the Illumina MiSeq platform. 
Sequence processing and picking of clusters of closely related sequences (operational taxonomic units (OTUs) at 
97% sequence identity) were performed in QIIME version 1.9.146. OTU data were filtered using a threshold of at 
least 0.1% of sequence reads in two or more samples.
Measurements of microbial maturity and diversity. We employed a Random Forests machine learn-
ing model to determine microbiota maturity15,17. The model was generated from an analysis of faecal samples 
collected from members of a Malawian cohort from birth through the second year of life. The model predicts 
microbiota age (state of development) based on the abundances of 25 age-discriminatory OTUs17. Microbiota 
ages of study members predicted by this model were compared to the median microbiota age of chronologically 
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age-matched children in the healthy reference group to generate microbiota-for-age Z-scores (MAZ-scores). The 
data for the healthy reference group of children were obtained from healthy Malawian children and microbiota 
maturity was calculated as reported earlier15.
Microbiota diversity (based on mean alpha diversity of OTUs in each sample) was measured by calculating the 
Shannon diversity index using the phyloseq package in R47. Shannon index takes into account both richness and 
evenness of OTUs in each sample. A larger value indicates higher level of diversity48. For these analyses, Shannon 
index and MAZ scores were calculated at 6, 12 and 18 mo. Shannon index and MAZ scores were calculated with 
OTU data that were rarefied to 5000 reads.
Measurement of growth and inflammation outcomes. Growth was assessed as described previ-
ously43. The z-score growth variables (WAZ, LAZ, WLZ, HCZ) were calculated by standardizing for age and 
sex using the WHO Child Growth Standards49. The changes in LAZ, WAZ, WLZ, and HCZ were calculated by 
taking the difference in z-score between time points, and then dividing by the number of days between the two 
measurements. The value was then multiplied by the standard number of days for each 6-mo period. Values below 
−2.0 for WAZ, LAZ, WLZ and HCZ were considered to indicate underweight, stunting, wasting and small head 
circumference, respectively.
To assess inflammation, Alpha-1 acid glycoprotein (AGP) and C-reactive protein (CRP) were analysed from 
plasma by immunoturbidimetry on the Cobas Integra 400 system auto-analyser (F. Hoffmann-La Roche Ltd, 
Basel, Switzerland) and reported as g/L and mg/L respectively. High AGP was defined as having AGP value 
>1.0 g/L and high CRP as having CRP value >5.0 mg/L.
Statistical analysis. All data were analysed using SAS version 9.4 (Cary, NC). Children whose age at a given 
time point was outside of the pre-specified range for these analyses were excluded. At 6 mo children older than 8 
mo were excluded (n = 13), at 12 mo children older than 15 mo were excluded (n = 5) and at 18 mo children older 
than 21 mo were excluded (n = 2). AGP and CRP were natural log transformed and the β-values and confidence 
intervals were back-transformed. For continuous outcomes, linear regression (proc glimmix) was used and the 
β-values and SEs of the predictor are presented. For dichotomous outcomes, logistic regression (proc glimmix) 
was used and the odds ratios and confidence intervals are presented. These models were fully adjusted for the 
following pre-specified covariates: intervention group; child age on day of stool collection; maternal age, height, 
body mass index, parity, education, HIV status, and hemoglobin at enrollment; household assets, food security, 
source of drinking water (tap water vs any other source), residential location and access to sanitary facility (water 
closet or ventilation improved pit latrine vs. none or regular pit latrine); season at time of stool sample collection; 
mode of delivery (vaginal or cesarean); site of delivery; and child sex. The residuals were assessed for outliers and 
normality. Extreme values were winsorized to the 2.5th and 97.5th percentile, and a sensitivity analysis was con-
ducted with and without winsorized values. The models were inspected for multicollinearity and any covariate 
that was associated with the predictor with a Spearman’s correlation coefficient greater than 0.7 was removed.
To address the hypotheses regarding growth outcomes, we used repeated measures ANCOVA to assess 
whether Shannon index or MAZ were predictive of change in anthropometric z-scores. The model included two 
age intervals. For the first age interval, the response variable was the change in anthropometric z-score between 
6 and 12 mo and the predictor was MAZ or Shannon index at 6 mo. The anthropometric z-score at 6 mo was 
included as a covariate to control for status at the beginning of the time interval. For the second age interval, the 
response variable was the change in anthropometric z-score between 12 and 18 mo, the predictor was MAZ or 
Shannon index at 12 mo, and the growth measurement z-score at 12 mo was included as a covariate. If an obser-
vation for growth or microbiota was missing at one time point, the observation was included for the other time 
point. The beta-value of MAZ or Shannon index across both intervals was of interest but could not be interpreted 
from a model that also included the interaction between interval and predictor. Therefore, a separate model was 
conducted that contained a term for the age interval and a term for the predictor, and the beta-value from this 
predictor was reported. For these models, we first examined the interaction between time interval and the pre-
dictor. If this interaction was significant, it meant that the relationship of the predictor to the outcome differed 
between the two age intervals, and we then assessed each age interval separately. The β-values of the predictor are 
presented. These models were fully adjusted and include the covariates previously described.
To test the hypothesis that MAZ and Shannon index are related to concurrent inflammation, we performed 
linear regression in which the predictor was either MAZ or Shannon index at 6 mo, and the outcome was inflam-
mation as measured by log-transformed CRP or log-transformed AGP. Additionally, logistic regression models 
were performed to assess whether MAZ or Shannon index at 6 mo was associated with high AGP or high CRP. 
To test the hypothesis that MAZ and Shannon index are related to future inflammation, we repeated the models 
described above, except that the outcomes were measured at 18 mo and the predictors were measured at 6 or 12 
mo. The β-values or odds ratios of the predictor are presented. These models were fully adjusted and include the 
covariates previously described.
For taxa-specific analyses, we used two filters to restrict the OTUs used in analysis. The first filter excluded 
OTUs that were present in less than 5% of the participants at a given time point. The second filter excluded OTUs 
with very low abundances of less than 0.1% in a given sample. To identify which taxa were related to growth 
and inflammation, we performed another set of regression model. We focused this analysis on outcomes for 
which there was a significant relationship with MAZ or Shannon index. The distributions of the OTU abundances 
were frequently zero-inflated and non-normal. Therefore, we condensed the OTU abundance data into two sep-
arate variables: a) a binary variable for whether the OTU was present (at any abundance), and b) a variable with 
three categories of OTU abundance (OTU absent, OTU present at a count less than the median, OTU present 
at a count greater than the median). These models were fully adjusted for all the pre-specified covariates. The 
Benjamini-Hochberg correction for multiple hypotheses was applied, using a false discovery rate (FDR) of 0.15.
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Data Availability
The datasets generated during and/or analysed during the current study are available from the corresponding 
author on reasonable request. The V4 16S rRNA sequence data generated in this study are available through the 
European Nucleotide Archive (Accession Number PRJEB29433).
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